Bioterrorism Week
Susan Hasty, Publisher
Table of Contents . . . October 31st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Anthrax - Fast-tracked anthrax drug, Anthim, advances into human clinical trials
Bioterrorism - Exploiting Hurricane Katrina to protect against food terrorism
Bioterrorism - RiVax safe against ricin
Smallpox - Vaccine, previously left unused in WHO eradication program, provides efficient protection
Bioterrorism - Proposal submitted to supply Imvamune smallpox vaccine to U.S. government
Bioterrorism - U.S. NIH awards $4.6 million challenge grant for R&D of intranasal anthrax vaccine
Drug Development - Hematological cancer drug maker reports on developmental pipeline
Immunization - Vaccinia virus H3L envelope protein is key contributor to human protection against poxvirus
Monkeypox - Previous smallpox vaccination maintains immunity against monkeypox for decades
Vaccine Development - Proposal to supply a stockpile of smallpox vaccine submitted to U.S. government
West Nile Virus - VGTI researchers receive $12.6 million to study West Nile virus in the elderly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
